Education
About Us
Working with TipRanks
Follow Us
PuraPharm Corp. Ltd. (HK:1498)
:1498
RESEARCH TOOLSreports
See the Price Targets and Ratings of:
1498 Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
HK$0.5
Hold
4.17%
Upside
Reiterated
07/29/25
The most significant factor affecting PuraPharm's stock score is its financial performance, which is hindered by declining revenues and high leverage. Technical analysis indicates moderate stability, while poor valuation due to negative earnings impacts the score negatively. No earnings call or corporate events data is available to influence the score.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
HK$0.5
Hold
4.17%
Upside
Reiterated
07/29/25
The most significant factor affecting PuraPharm's stock score is its financial performance, which is hindered by declining revenues and high leverage. Technical analysis indicates moderate stability, while poor valuation due to negative earnings impacts the score negatively. No earnings call or corporate events data is available to influence the score.
1498 Analyst Recommendation Trends
Rating
May 25
Jun 25
Jul 25
Strong Buy
0
0
0
Buy
0
0
0
Hold
1
2
4
Sell
0
0
0
Strong Sell
0
0
0
total
1
2
4
Each month's total comprises the sum of three months' worth of ratings.
1498 Stock Forecast FAQ
What is HK:1498’s average 12-month price target, according to analysts?
Based on analyst ratings, PuraPharm Corp. Ltd.’s 12-month average price target is 0.50.
What is HK:1498’s upside potential, based on the analysts’ average price target?
PuraPharm Corp. Ltd. has 4.17% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PuraPharm Corp. Ltd. a Buy, Sell or Hold?
PuraPharm Corp. Ltd. has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is PuraPharm Corp. Ltd.’s share price target?
The average share price target for PuraPharm Corp. Ltd. is 0.50. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$0.50 ,and the lowest forecast is HK$0.50. The average share price target represents 4.17% Increase from the current price of HK$0.48.
The highest analyst share price target is HK$0.50 ,and the lowest forecast is HK$0.50. The average share price target represents 4.17% Increase from the current price of HK$0.48.
What do analysts say about PuraPharm Corp. Ltd.?
PuraPharm Corp. Ltd.’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of PuraPharm Corp. Ltd.?
To buy shares of HK:1498, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.